205 related articles for article (PubMed ID: 7055809)
21. Dynamic features of luteal secretory granules: ultrastructural changes during the course of pregnancy in the cow.
Fields MJ; Dubois W; Fields PA
Endocrinology; 1985 Oct; 117(4):1675-82. PubMed ID: 4029092
[TBL] [Abstract][Full Text] [Related]
22. Cytodifferentiation of the nonciliated bronchiolar epithelial (Clara) cell during rabbit lung maturation: an ultrastructural and morphometric study.
Plopper CG; Alley JL; Serabjitsingh CJ; Philpot RM
Am J Anat; 1983 Jul; 167(3):329-57. PubMed ID: 6881072
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines.
Top S; Vessières A; Leclercq G; Quivy J; Tang J; Vaissermann J; Huché M; Jaouen G
Chemistry; 2003 Nov; 9(21):5223-36. PubMed ID: 14613131
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition.
Mueck AO; Seeger H; Wallwiener D
Climacteric; 2003 Sep; 6(3):221-7. PubMed ID: 14567770
[TBL] [Abstract][Full Text] [Related]
25. Can transforming growth factor-beta1 and retinoids modify the activity of estradiol and antiestrogens in MCF-7 breast cancer cells?
Czeczuga-Semeniuk E; Anchim T; Dziecioł J; Dabrowska M; Wołczyński S
Acta Biochim Pol; 2004; 51(3):733-45. PubMed ID: 15448735
[TBL] [Abstract][Full Text] [Related]
26. Ultrastructure of aldosterone secreting adrenal adenomata.
Mazzocchi G; Robba C; Gottardo G; Meneghelli V; Nussdorfer GG
J Submicrosc Cytol; 1982 Jan; 14(1):179-85. PubMed ID: 7108995
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of human breast cancer cell proliferation with estradiol metabolites is as effective as with tamoxifen.
Seeger H; Huober J; Wallwiener D; Mueck AO
Horm Metab Res; 2004 May; 36(5):277-80. PubMed ID: 15156405
[TBL] [Abstract][Full Text] [Related]
28. Estrogen inhibition of a Mr 39,000 glycoprotein secreted by human breast cancer cells.
Bronzert D; Silverman S; Lippman M
Cancer Res; 1987 Mar; 47(5):1234-8. PubMed ID: 3815334
[TBL] [Abstract][Full Text] [Related]
29. Effects of estradiol and progestogens on tumor-necrosis factor-alpha-induced changes of biochemical markers for breast cancer growth and metastasis.
Seeger H; Wallwiener D; Mueck AO
Gynecol Endocrinol; 2008 Oct; 24(10):576-9. PubMed ID: 19012101
[TBL] [Abstract][Full Text] [Related]
30. Three novel hormone-responsive cell lines derived from primary human breast carcinomas: functional characterization.
Vázquez SM; Mladovan A; Garbovesky C; Baldi A; Lüthy IA
J Cell Physiol; 2004 Jun; 199(3):460-9. PubMed ID: 15095293
[TBL] [Abstract][Full Text] [Related]
31. Comparison of possible carcinogenic estradiol metabolites: effects on proliferation, apoptosis and metastasis of human breast cancer cells.
Seeger H; Wallwiener D; Kraemer E; Mueck AO
Maturitas; 2006 Apr; 54(1):72-7. PubMed ID: 16213115
[TBL] [Abstract][Full Text] [Related]
32. The effect of progesterone, testosterone and synthetic progestogens on growth factor- and estradiol-treated human cancerous and benign breast cells.
Krämer EA; Seeger H; Krämer B; Wallwiener D; Mueck AO
Eur J Obstet Gynecol Reprod Biol; 2006 Nov; 129(1):77-83. PubMed ID: 16460873
[TBL] [Abstract][Full Text] [Related]
33. Estrogen-induced apoptosis in a breast cancer model resistant to long-term estrogen withdrawal.
Lewis JS; Osipo C; Meeke K; Jordan VC
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):131-41. PubMed ID: 15862958
[TBL] [Abstract][Full Text] [Related]
34. Effects of variations in calcium concentration on parathyroid morphology in vitro.
Boquist L; Lundgren E
Lab Invest; 1975 Dec; 33(6):638-47. PubMed ID: 1202283
[TBL] [Abstract][Full Text] [Related]
35. Opposing effects of estradiol- and testosterone-membrane binding sites on T47D breast cancer cell apoptosis.
Kampa M; Nifli AP; Charalampopoulos I; Alexaki VI; Theodoropoulos PA; Stathopoulos EN; Gravanis A; Castanas E
Exp Cell Res; 2005 Jul; 307(1):41-51. PubMed ID: 15922725
[TBL] [Abstract][Full Text] [Related]
36. Comparative study of the surface ultrastructure of ten human breast cancer cell lines.
Rizk NN
Arch Anat Microsc Morphol Exp; 1985; 74(3):205-14. PubMed ID: 3833058
[TBL] [Abstract][Full Text] [Related]
37. A possible regulatory role of 17beta-estradiol and tamoxifen on glyoxalase I and glyoxalase II genes expression in MCF7 and BT20 human breast cancer cells.
Rulli A; Antognelli C; Prezzi E; Baldracchini F; Piva F; Giovannini E; Talesa V
Breast Cancer Res Treat; 2006 Mar; 96(2):187-96. PubMed ID: 16319983
[TBL] [Abstract][Full Text] [Related]
38. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells.
Cos S; Fernández R; Güézmes A; Sánchez-Barceló EJ
Cancer Res; 1998 Oct; 58(19):4383-90. PubMed ID: 9766668
[TBL] [Abstract][Full Text] [Related]
39. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
Liu X; Pisha E; Tonetti DA; Yao D; Li Y; Yao J; Burdette JE; Bolton JL
Chem Res Toxicol; 2003 Jul; 16(7):832-7. PubMed ID: 12870885
[TBL] [Abstract][Full Text] [Related]
40. Effect of 17 beta-estradiol, progesterone, synthetic progestins, tibolone, and tibolone metabolites on vascular endothelial growth factor mRNA in breast cancer cells.
Mirkin S; Wong BC; Archer DF
Fertil Steril; 2005 Aug; 84(2):485-91. PubMed ID: 16084894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
